Substituted N-biphenylyl lactams
AssigneeOrtho Pharmaceutical Corporation
InventorsWilliam V. Murray, Michael P. Wachter
Life of this patent
Estimating the term…
Loading patent…
AssigneeOrtho Pharmaceutical Corporation
InventorsWilliam V. Murray, Michael P. Wachter
Estimating the term…
This invention relates to novel N-biphenylyl lactam compounds having a substituted methylidene or methyl moiety adjacent to the lactam nitrogen, and pharmaceutically acceptable salts thereof. The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy. The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention.
A compound of the following formula:
Dependencies are inferred from the claim text.